Sage Mandel

Director/Miembro de la Junta en CELYAD ONCOLOGY SA .

Consumer Services

Finance

Health Technology

Perfil

Sage Mandel currently works at Celyad Oncology SA, as Non-Executive Director.
Ms. Mandel also formerly worked at Essex Woodlands Management, Inc., as Vice President from 2021 to 2023.
Ms. Mandel received her graduate degree in 2015 from the University of Pennsylvania.

Cargos activos de Sage Mandel

Empresas	Cargo	Inicio
CELYAD ONCOLOGY SA	Director/Miembro de la Junta	-

Todos los cargos activos de Sage Mandel

Antiguos cargos conocidos de Sage Mandel.

Empresas	Cargo	Fin
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Analista de Capital Privado	31/12/2020

Ver el detalle de la experiencia de Sage Mandel.

Formación de Sage Mandel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Sage Mandel.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Finance
Celyad Oncology SA Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products	Health Technology